Life Science Leader Magazine Supplements

CRO Leadership Awards 2013

The vision of Life Science Leader is to be an essential business tool for life science executives. Our content is designed to not only inform readers of best practices, but motivate them to implement those best practices in their own businesses.

Issue link: https://lifescienceleadermag.epubxp.com/i/111709

Contents of this Issue

Navigation

Page 30 of 45

Rho ��� Chapel Hill, NC www.rhoworld.com ��� (919) 408-8000 key locations: Chapel Hill, NC contact: Kelly Giles ��� kelly_giles@rhoworld.com Drug Life Cycle Stages: Research & Development ���Clinical (Phase 1, Phase 2, and Phase 3) Main Service Areas: Clinical SERVICES & CAPABILITIES: Regulatory guidance, protocol development, clinical operations, data management, SAE management, statistical analysis & consulting, project management, CDISC expertise, and IVRS/IWRS THERAPEUTIC AREAS: CNS, immunology, respiratory, dental, ophthalmology, dermatology, hematology, and infectious diseases KEY INDUSTRY PARTNERS: Medidata ���Rho is committed to hiring smart people who enjoy thinking both critically and creatively. The innovative people we hire are always improving productivity and our clients notice and appreciate it. We���ve been providing clinical trials services for more than 28 years now. Over that time we have built a wealth of knowledge and expertise. That experience enables us to deliver high quality regulatory services and guidance to our clients across all phases of drug development.��� ��� Russ Helms, CEO (Laura Helms Reece, CEO, pictured left) SCYNEXIS ��� Research Triangle Park, NC www.scynexis.com ��� (919) 544-8600 key locations: Research Triangle Park, NC contact: Clare Murray ��� clare.murray@scynexis.com Drug Life Cycle Stages: Research & Development ��� Discovery, Preclinical Drug Substance Production: Primary Process Development, Drug Substance Production Main Service Areas: Bioanalytical, Preclinical SERVICES & CAPABILITIES: SCYNEXIS delivers efficient and innovative drug discovery and development solutions to our global health, life science, and pharmaceutical partners, through services that include integrated pharmaceutical solutions, discovery research and integrated parasitology. THERAPEUTIC AREAS: Immunology, antiviral, infectious disease, ophthalmology, dermatology, neglected disease, and antiparastic ���We are pleased to be recognized for our leadership and proven track record of delivering preclinical and clinical candidates to our clients and partners. At SCYNEXIS, we put our expertise and problem solving skills to work for all of our clients so they can confidently move from concept to clinic.��� ��� Dr. Yves Ribeill, president & CEO Seventh Wave Laboratories ��� Chesterfield, MO www.7thwavelabs.com ��� (636) 519-4885 key locations: Chesterfield, MO and St. Louis, MO contact: Jody DeBold ��� jdebold@7thwavelabs.com Drug Life Cycle Stages: Research & Development ��� Discovery, Preclinical Main Service Areas: Bioanalytical, Preclinical SERVICES & CAPABILITIES: Preclinical PK/PD/TK studies and analysis, pharmacology and disease models, toxicology studies, in vitro ADME, dissolution analysis, histology, immunohistochemistry/ immunofluorescence, pathology, image analysis, stereology, clinical PK/PD analysis, and preclinical consulting THERAPEUTIC AREAS: Various ���We believe in putting the needs of our clients first, and we understand that time is money. Therefore, we respond quickly and we remain flexible, allowing the client to customize each project to meet their needs. Our multidisciplinary group of experts joins the sponsor as an extension of their internal team and dedicates themselves to each study as if it was their own.��� ��� Dr. John Sagartz, CEO The CRO Leadership Awards 2013 29

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CRO Leadership Awards 2013